Stock Events

Veritas In Silico 

¥932
5
+¥18+1.97% Friday 06:15

Statistics

Day High
950
Day Low
906
52W High
3,475
52W Low
901
Volume
22,200
Avg. Volume
60,606
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 130A.TSE. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap18.24B
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis, which is foundational to the type of research and development Veritas In Silico conducts.
CRISPR Therapeutics
CRSP
Mkt Cap4.63B
CRISPR Therapeutics is involved in gene editing, a field closely related to the genetic analysis and manipulation services provided by Veritas In Silico.
Editas Medicine
EDIT
Mkt Cap411.19M
Editas Medicine operates in the genome editing industry, directly competing with Veritas In Silico in the development of genomic medicines.
Intellia Therapeutics
NTLA
Mkt Cap2.42B
Intellia Therapeutics is a leading genome editing company, making it a direct competitor in the field of genomics and genetic research.
Pacific Biosciences of California
PACB
Mkt Cap452.11M
Pacific Biosciences of California offers sequencing systems that compete with the genomic analysis technologies used by Veritas In Silico.
Bionano Genomics
BNGO
Mkt Cap39.82M
Bionano Genomics provides tools for genomic analysis, competing in the same space as Veritas In Silico with their focus on genetic research and diagnostics.
Twist Bioscience
TWST
Mkt Cap3.14B
Twist Bioscience operates in the synthetic biology space, providing products that compete with Veritas In Silico's research and development in genomics.
Qiagen NV
QGEN
Mkt Cap9.48B
Qiagen N.V. offers sample to insight solutions that are used in the same fields as Veritas In Silico, making them a competitor in the genomics and molecular diagnostics market.
Guardant Health
GH
Mkt Cap3.76B
Guardant Health is involved in cancer diagnostics and genomic health services, competing with Veritas In Silico in the precision medicine and genomics field.

About

Show more...
CEO
ISIN
JP3155340007

Listings

TSE
Japan
130A.TSE